...CDKN1B) - Cyclin-dependent kinase inhibitor 1B Selina Koch, Executive Editor; Winnie Pong, Associate Editor, Data & Analytics Cord Blood Registry Otonomy...

...umbilical cord plasma proteins revitalize hippocampal function in aged mice." Nature (2017) Michael Leviten, Senior Writer Alkahest Inc. Cord Blood Registry Stanford...

...Acousia plans to deliver its compounds locally to the inner ear. AMAG Pharmaceuticals Inc .'s Cord Blood Registry...

...Cord Blood Registry for $700 million in cash from private equity firm GTCR (see BioCentury, July 13). Cord Blood Registry...

...Ad5) to deliver the atonal homolog 1 (ATOH1; HATH1) gene Acquired hearing loss Phase I/II Cord Blood Registry...

...shares were valued at $64.95; AMAG lost $0.87 to $63.90 on Friday. AMAG is acquiring Cord Blood Registry...

...AMAG will acquire stem cell company Cord Blood Registry from private equity firm GTCR for $700 million in...
...from Jefferies and Barclays to fund the acquisition. AMAG reported $53.3 million in 2014 revenue. Cord Blood Registry...

...AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) will acquire stem cell company Cord Blood Registry (San Bruno, Calif.) for $700 million...

...months with acquired hearing loss. The trial is sponsored by the Memorial Hermann Healthcare System. Cord Blood Registry...

...brain development disorder or obstructive hydrocephalus. The trial is sponsored by Georgia Health Sciences University. Cord Blood Registry...